Glaukos Corp GKOS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 18.57
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 907
- Website
- https://www.glaukos.com
Comparables
Valuation
|
Metric
|
GKOS
|
SIBN
|
SGHT
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 10.57 | 3.37 | 3.21 |
Price/Sales | 18.57 | 3.62 | 4.04 |
Price/Cash Flow | — | — | — |
Price/Earnings
GKOS
SIBN
SGHT
Financial Strength
|
Metric
|
GKOS
|
SIBN
|
SGHT
|
|---|---|---|---|
Quick Ratio | 4.46 | 7.99 | 10.39 |
Current Ratio | 5.48 | 9.17 | 11.01 |
Interest Coverage | −11.42 | −12.97 | −9.17 |
Quick Ratio
GKOS
SIBN
SGHT
Profitability
|
Metric
|
GKOS
|
SIBN
|
SGHT
|
|---|---|---|---|
Return on Assets (Normalized) | −11.42% | −6.03% | −22.80% |
Return on Equity (Normalized) | −21.08% | −8.10% | −31.99% |
Return on Invested Capital (Normalized) | −12.47% | −8.97% | −22.08% |
Return on Assets
GKOS
SIBN
SGHT
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Qmcswrmjq | Zfxwzk | $195.6 Bil | |||
| Stryker Corp
SYK
| Bynqkxgypc | Znkc | $137.3 Bil | |||
| Boston Scientific Corp
BSX
| Dtshdzbj | Qvvcsp | $122.7 Bil | |||
| Medtronic PLC
MDT
| Ksxggsg | Bggxnx | $114.6 Bil | |||
| Edwards Lifesciences Corp
EW
| Xfjpskft | Rdmrslm | $40.1 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Gwsy | Dhjky | $30.7 Bil | |||
| DexCom Inc
DXCM
| Vjjqvjkb | Wwhl | $27.0 Bil | |||
| Steris PLC
STE
| Vwpsvjvk | Ctqxpn | $23.6 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Ngsdzhcgxm | Tgg | $22.0 Bil | |||
| Insulet Corp
PODD
| Gqflhrjvpg | Ywgjpsd | $16.3 Bil |
United States